Concepedia

Rishab Ramapriyan

RR

8

Publications

794

Citations

8

H-Index

2019

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Shandong Tumor Hospital

Shandong First Medical University

Allegheny General Hospital

Harvard University

Rishab Ramapriyan is an author at The University of Texas MD Anderson Cancer Center specializing in radiation oncology, immunotherapy, and lung cancer.

ORCID

Top concepts

Publications per year

2019–2023

8

Publications

8

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

Hampartsoum B. Barsoumian, Rishab Ramapriyan, Ahmed Younes et al. · Journal for ImmunoTherapy of Cancer · 2020 · 199 citations · Full text

Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation–Related Abscopal Responses

James W. Welsh, Chad Tang, Patricia M. de Groot et al. · Cancer Immunology Research · 2019 · 141 citations · Full text

Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy

Hari Menon, Dawei Chen, Rishab Ramapriyan et al. · Journal for ImmunoTherapy of Cancer · 2019 · 122 citations · Full text

Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials

Dawei Chen, Hari Menon, Vivek Verma et al. · Journal for ImmunoTherapy of Cancer · 2020 · 106 citations · Full text

Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy

Dawei Chen, Roshal R. Patel, Vivek Verma et al. · Radiotherapy and Oncology · 2020 · 99 citations

, , +8

Rows per page

1–5 of 8